Global Targeted Protein Degradation Market By Offering (Active Degraders (PROTACs), LYTAC (Lysosome Targeting Chimera) Technology, Autophagosome-tethering Compound (ATTEC), Autophagy-targeting Chimera (AUTAC) System, TAG Degradation Platform (aRAG, dTAG), Degrader Building Blocks, Ubiquitin Proteasome System Proteins and Assays, Assays for Protein Degradation, Custom Degrader Services, SARDS and SERDs, Others); By Potential Targets (Intracellular Proteins, Extracellular Proteins; Transmembrane Proteins, Intracellular Proteins; Damaged Organelles Associated with Specific Proteins, Intracellular Proteins; Non-protein Autophagy Substrates); By Type of Diseases (Breast Cancer, Colorectal Cancer, Prostate Cancer, Alzheimer’s disease, Liver Fibrosis, Parkinson’s disease, Psoriasis, Rheumatoid Arthritis, Autoimmune Diseases, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030

Report ID :AMI-1241 | Category : Healthcare | Published Date : August, 2022 | Pages : 402 | Format :PDF